National Partner – BlueRock Therapeutics
BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological, ophthalmic, cardiovascular, and immunological diseases. BlueRock is a wholly owned, independently operated subsidiary of Bayer AG and a cornerstone of its newly formed Cell & Gene Therapy platform.
For more information, about BlueRock Therapeutics, visit www.bluerocktx.com.
